Your trusted source for investing success

Tag: treatment

DelMar Pharmaceuticals Receives Approval from China’s Human Genetic Resources Administration to Initiate Phase 2 Clinical Trial in Newly Diagnosed GBM

DelMar Pharmaceuticals Receives Approval from China’s Human Genetic Resources Administration to Initiate Phase 2 Clinical Trial in Newly Diagnosed GBM

DelMar Pharmaceuticals, Inc. (NASDAQ: DMPI), a biopharmaceutical company focused on the development of new cancer therapies, today announced that the Human Genetic Resources Administration of China (HGRAC), has approved the Company’s application to initiate a Phase 2 safety and efficacy study of its lead product candidate VAL-083 in newly diagnosed MGMT-unmethylated glioblastoma

Maricann CEO Benjamin Ward discusses why Medical Marijuana is really taking off

Maricann CEO Benjamin Ward discusses why Medical Marijuana is really taking off

Benjamin Ward, CEO of Maricann Group Inc., a vertically-integrated greenhouse producer and distributor of medical cannabis. Toronto, Canada-based Maricann is now building global teams in rapidly expanding European markets as well.

As quoted in the article:
“European markets are increasingly important to the cannabis sector. Each has a well-funded medical system, residents who

Forget the US. Here’s where medical marijuana is really taking off

Forget the US. Here’s where medical marijuana is really taking off

Benjamin Ward, CEO of Maricann Group Inc (CSE:MARI) has recently commented on some of the changes within the cannabis industry. Some of these changes are stemming from Canada’s upcoming legalization and a changing of attitudes.

There is a global shift in cannabis towards Western Europe.
That’s where the action in

Heron’s Woodlawn G2 Lens Drilling Returns High Grade Intercepts

Heron’s Woodlawn G2 Lens Drilling Returns High Grade Intercepts

Heron Resources Limited (ASX:HRR TSX:HER, “Heron” or the “Company”) is pleased to provide an exploration update from the drilling program currently underway at its wholly-owned Woodlawn Zinc-Copper Project, located 250km south-west of Sydney, New South Wales, Australia.

Initial assays received from current G2 Lens drilling program, including:
4.7m at 53.0% ZnEq[1] from

Enter Your Log In Credentials
×

Privacy & Legal Policy

Privacy Policy

×
Investing News Network